Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Sep 21 - Sep 26
WEDNESDAY, July 23, 2025 (HealthDay News) -- Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with reduced type 2 diabetes mellitus (T2DM)-related dementia risk compared with metformin, according to a study published online July 22 in BMJ Open Diabetes Research & Care.Mingyang Sun, from the People's Hospital of Zhengzhou University in China, and colleagues conducted a retrospective cohort study using data from a global health research network between 2004 and 2024 to examine the comparative effectiveness of GLP-1 RAs and metformin in reducing dementia risk
Always verify these registrations before proceeding, as the MHRA has issued warnings about unregulated sources, particularly during recent supply shortages
Children have had the lowest per capita costs, averaging about $1,500 per year
What are these drugs, and how do they work
It might make your body start to go to sleep later and later. While going to bed and waking up at the same time every day can lead to better working internal clocks, there are other behavioral modifications that can lead to improved sleep
Very common side effects (affecting more than 1 in 10 people): Nausea: This is the most frequently reported side effect, particularly during the initial weeks of treatment or following dose increases
